CONDITION
Renal Lymphoma in Cats
Renal lymphoma is a cancer of white blood cells that infiltrates both kidneys. The malignant cells crowd into the kidney tissue, often causing the kidneys to enlarge and lose their ability to filter waste from the blood. Cats with this condition tend to show signs related to kidney dysfunction — reduced appetite, weight loss, increased thirst, and changes in urination — though these signs can develop quickly or unfold over weeks. Male cats appear to be over-represented, occurring roughly twice as often in males as in females. Most affected cats are middle-aged or older, with a median age around eight years. Historically, around half of cats with renal lymphoma tested positive for feline leukaemia virus, but since widespread introduction of FeLV vaccination the median age has increased and most cases are now not associated with FeLV infection. This page explores what renal lymphoma can look like in daily life, what is happening inside the kidneys, how the condition is investigated through imaging and sampling, and what approaches exist for managing it.
Why this matters now
Renal lymphoma in cats tends to appear in middle-aged to older animals, with most cases identified in cats between seven and twelve years of age, though younger cats can also be affected. Male cats appear to be over-represented, with studies showing renal lymphoma occurring roughly twice as often in males as in females, though females can also be affected. The condition is not strongly associated with particular breeds, and most cases occur in domestic shorthair and longhair cats. Feline leukaemia virus infection was historically a significant risk factor, but with widespread vaccination and testing, many cases today arise in cats without known viral infection.
The condition often develops over weeks to months, with signs becoming gradually more apparent as kidney function declines and tumour burden increases. The pace can vary: some cats show subtle changes over an extended period, whilst others deteriorate more quickly once clinical signs begin. Because the kidneys have considerable reserve capacity, early disease may produce few outward signs, and owners often notice changes only once a significant portion of kidney tissue has been affected. Once signs are present, progression tends to continue without intervention, though the rate and pattern differ between individuals.
Signals & patterns
Early signals
Increased drinking and urination
An owner may notice the water bowl being emptied more frequently, or the litter tray becoming wetter or heavier than usual. This occurs because damaged kidney tissue loses the ability to concentrate urine, so the body compensates by drinking more to maintain hydration.
Gradual reduction in appetite
A cat may show less interest in food, eating smaller portions or leaving meals unfinished over a period of days to weeks. This can reflect the accumulation of waste products in the blood, which often produces a feeling of nausea or general malaise.
Quiet lethargy or withdrawal
The cat may spend more time resting, show less interest in play or interaction, or choose to be alone more often. These changes can be subtle and may be mistaken for normal ageing, particularly in older animals.
Weight loss
Owners may notice the cat feeling bonier when picked up, or the spine and hips becoming more prominent. Weight loss tends to develop gradually and may only become obvious when comparing the cat's appearance over weeks or months.
Later signals
Vomiting
Cats may vomit intermittently, often bringing up clear fluid, bile, or partially digested food. This reflects the build-up of uraemic toxins—waste products the kidneys can no longer clear—which irritate the stomach lining and trigger nausea.
Palpable abdominal masses
In some cases, one or both kidneys may become enlarged enough to be felt through the abdomen, either by the owner or during a clinical examination. This occurs when tumour tissue expands the kidney beyond its usual size, though not all renal lymphomas produce obvious enlargement.
Marked weakness or reluctance to move
A cat may become noticeably less steady, struggle to jump or climb, or spend most of the day lying down. This can reflect profound metabolic disturbance, including anaemia, electrolyte imbalance, and the cumulative effects of uraemia on muscle and nerve function.
Click to read about the biological mechanisms
How this is usually investigated
Investigation typically begins with a detailed history and physical examination, focusing on the pattern of signs over time and palpation of the abdomen to assess kidney size and shape. Blood and urine tests follow to evaluate kidney function and identify markers that suggest infiltrative disease rather than other causes of kidney dysfunction. Imaging and tissue sampling help clarify the nature and extent of the process, with the combination of findings shaping the overall picture.
Chemistry panel
Abdominal ultrasound
Cytology
Histopathology
Complete blood count
Options & trade-offs
Management approaches vary depending on the extent of kidney involvement, the presence of disease elsewhere, the cat's overall health, and what feels workable for the household. Some owners and veterinary teams focus on symptom control and maintaining quality of life, whilst others incorporate treatments aimed at slowing tumour growth. The path taken tends to reflect a combination of medical considerations and individual circumstances, and different combinations suit different situations.
Chemotherapy
Renal lymphoma in cats is usually high-grade (large-cell) disease, so lymphoma cells are often sensitive to chemotherapy, and first-line treatment typically involves multi-agent injectable protocols such as CHOP-based regimens, combining drugs including vincristine, cyclophosphamide, doxorubicin, and prednisolone, which can reduce tumour burden and, in some cases, improve kidney function temporarily by shrinking infiltrating tissue. Chlorambucil-based protocols, paired with prednisolone, are generally reserved for lower-grade, indolent lymphoma rather than for renal lymphoma, which carries a notable risk of spreading to the central nervous system—a factor that shapes protocol selection and prognosis. Treatment is typically administered over several weeks to months, with response monitored through repeat blood tests and imaging. Some cats experience periods of improved appetite, energy, and biochemical stability.
Trade-offs: Response varies between individuals, and not all cats tolerate chemotherapy equally well. Side effects such as nausea, suppressed white cell counts, or increased susceptibility to infection can occur, and the duration of benefit is unpredictable. Chemotherapy does not cure renal lymphoma, and progression eventually resumes in most cases.
Supportive care for kidney dysfunction
Interventions such as fluid therapy, dietary modification to reduce protein waste load, anti-nausea medication, and appetite stimulants can help manage the consequences of reduced kidney function. Intravenous or subcutaneous fluids may be given to support hydration and help flush waste products, whilst medications address individual symptoms such as vomiting or low appetite. This approach focuses on comfort and maintaining a baseline level of function.
Trade-offs: Supportive care does not address the underlying tumour, and kidney function typically continues to decline over time. The intensity of care required can increase as the disease progresses, and some cats may find frequent fluid administration or medication stressful. This approach tends to suit situations where chemotherapy is not pursued or where initial response to treatment has been limited.
Corticosteroid monotherapy
Prednisolone alone can reduce lymphoma cell activity and tumour size in some cats, offering a simpler option than multi-drug chemotherapy. It may improve appetite, reduce nausea, and provide temporary biochemical improvement. The medication is typically given orally at home, with dose adjustments based on response and side effects.
Trade-offs: Corticosteroids can increase thirst and urination, which may be difficult to distinguish from kidney-related signs, and prolonged use carries risks such as immune suppression, muscle wasting, or diabetes. Response tends to be shorter-lived than with more intensive chemotherapy protocols, and tumour resistance often develops over weeks to months.
Monitoring and symptom-based intervention
Some owners choose to observe their cat's comfort and quality of life closely, intervening selectively with medications or supportive measures as specific problems arise, rather than pursuing active tumour treatment. This may involve managing nausea, offering palatable food options, and adjusting the home environment to reduce stress and physical demands.
Trade-offs: This approach prioritises day-to-day well-being over disease control, and progression of kidney dysfunction and tumour growth continues unchecked. It tends to suit cats with limited tolerance for veterinary visits or medication, or situations where the likely duration of benefit from treatment is uncertain and quality of life is the guiding principle.
Common misconceptions
"If blood tests show kidney disease, the kidneys must be failing from age-related wear rather than cancer."
Elevated kidney markers such as creatinine and urea can result from many processes, including tumour infiltration, infection, inflammation, or degenerative change. The pattern of biochemical abnormality alone does not distinguish between these causes, and imaging or tissue sampling is often needed to clarify what is driving the dysfunction.
"Lymphoma always causes visible lumps or masses that can be felt from the outside."
Renal lymphoma often involves diffuse infiltration of the kidney tissue rather than discrete, palpable masses, and the kidneys themselves lie deep within the abdomen, surrounded by fat and other organs. In many cases, abnormalities are detected by imaging or blood tests rather than physical examination, and the absence of a palpable lump does not exclude the diagnosis.
"Once a cat is diagnosed with renal lymphoma, deterioration is always rapid and treatment offers little time."
The pace of progression varies considerably between individuals, influenced by tumour growth rate, the extent of kidney involvement, and response to treatment if pursued. Some cats experience weeks to months of stable or improved quality of life with chemotherapy or supportive care, whilst others may decline more quickly. The trajectory is not uniform, and each case unfolds differently.
Related conditions
Lymphoma in Cats
Lymphoma in cats can develop in many different sites throughout the body, and renal lymphoma represents one specific pattern in which both kidneys are infiltrated. The underlying disease process — uncontrolled multiplication of lymphocytes — is the same, though the location and resulting signs differ.
Feline Leukaemia Virus (FeLV)
Feline leukaemia virus infection has historically been associated with around half of renal lymphoma cases in cats, and the virus can contribute to the development of lymphoma in multiple sites. Since widespread FeLV vaccination, the proportion of renal lymphoma cases linked to the virus has declined, and most affected cats now test negative.
Alimentary Lymphoma in Cats
Alimentary lymphoma and renal lymphoma are both forms of lymphoma in cats, differing primarily in the organ system affected. In some cases, lymphoma may involve multiple sites, though each pattern tends to produce signs related to the tissues infiltrated — gastrointestinal signs in alimentary disease, and kidney-related signs in renal disease.
Acute Kidney Injury
Renal lymphoma can cause a rapid decline in kidney function as malignant cells replace normal tissue, and this may present in a way that resembles acute kidney injury. The two conditions share similar laboratory and clinical signs, though the underlying cause and timeframe differ, and distinguishing between them often requires imaging or tissue sampling.
Glomerulonephritis
Both glomerulonephritis and renal lymphoma can lead to protein loss in the urine and a decline in kidney function, and both may cause the kidneys to appear abnormal on imaging. The distinction often rests on biopsy or fine-needle sampling, as the patterns of kidney injury differ at the cellular level.
Understanding how renal lymphoma fits within the broader picture of kidney function and cancer behaviour in cats can help frame the conversations ahead. The Longevity & Healthspan pillar explores the ways different conditions interact with ageing and overall resilience, and related pages on chronic kidney disease and lymphoma in other body sites may offer useful context. These are conversations that can unfold over time, as the pattern becomes clearer and priorities take shape.